Join
Live feed
·
SECFilingvia Quantisnow
Obalon Therapeutics, Inc. logo

Obalon Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
OBLN· Obalon Therapeutics, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OBLN (Obalon Therapeutics, Inc.) and more on Quantisnow.